Morning Briefing
Summaries of health policy coverage from major news organizations
Amgen Drug Gets Boost In Fiscal Cliff Legislation
The New York Times reports that the legislation delayed a series of Medicare price restrains on a class of drugs that includes Sensipar, which is a money-making pills used by kidney diallysis patients.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
